ARCHIVES

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

This article is from The Cancer Letter archive.

Vol. 06 No. 29 | July 18, 1980

Download PDF Visit The Full Archive

Related Articles

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

NCI program announcement available, contract awards listed.

November 14, 2003

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

July 5, 2002

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011